Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 11, 2008Antimicrobial Agents and ChemotherapyOpen Access

Synergy of a Hepatitis C Virus (HCV) NS4A Antagonist in Combination with HCV Protease and Polymerase Inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

DWDavid WylesDenver Health Medical CenterKKKelly A. KaiharaBio-Rad (United States)RSRobert T. SchooleyAndover Eye Associates

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wyles et al. (2008) studied this question.

synapsesocial.com/papers/6aa12ce7e808e27a7c443949https://doi.org/10.1128/aac.01208-07
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identification of N,N-Disubstituted Phenylalanines as a Novel Class of Inhibitors of Hepatitis C NS5B Polymerase2003 · 69 citations
  2. 2Treatment of Patients with Recurrent Hepatitis C after Liver Transplantation with Peginterferon Alfa-2B Plus Ribavirin2006 · 87 citations
  3. 3Late breaking abstracts2006 · 23 citations
  4. 4Pyrrolidine-5,5-trans-lactams. 5. Pharmacokinetic Optimization of Inhibitors of Hepatitis C Virus NS3/4A Protease2003 · 21 citations
  5. 5Identification and Biological Characterization of Heterocyclic Inhibitors of the Hepatitis C Virus RNA-dependent RNA Polymerase2002 · 196 citations